Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?

Indianapolis, Indiana-based Eli Lilly and Company (LLY) discovers and develops various drugs and medicines. It operates as one of the largest pharmaceutical companies in the world and boasts a diverse portfolio of numerous successful drugs, including Mounjaro, Trulicity, Verzenio, and more. With a market cap of $816.7 billion, its operations span various countries in the Americas, EMEA, and the Indo-Pacific.

Despite its notable strengths, the pharma giant has lagged behind the broader market over the past year. LLY stock prices have gained 16.1% on a YTD basis and 9.5% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 16.5% gains in 2025 and 19.6% returns over the past year.